ロード中...

Inhibition of HER2-integrin signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression

HER2, an oncogenic receptor is overexpressed in about 25-30% of breast cancer patients. HER2 has been shown to play role in tumor promotion by having cross-talk with multiple oncogenic pathways in cancer cells. Our results show that Cucurbitacin B (CuB), a triterpenoid steroidal compound inhibited t...

詳細記述

保存先:
書誌詳細
主要な著者: Gupta, Parul, Srivastava, Sanjay K.
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2014
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4039119/
https://ncbi.nlm.nih.gov/pubmed/24729020
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!